# Filing Detail

Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-029269
Filing Date
2023-02-09
Accepted
2023-02-09 08:23:19
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | S-3 | d439520ds3.htm | S-3 | 255336
2 | EX-4.2 | d439520dex42.htm | EX-4.2 | 440428
3 | EX-5.1 | d439520dex51.htm | EX-5.1 | 24555
4 | EX-23.2 | d439520dex232.htm | EX-23.2 | 1710
5 | EX-FILING FEES | d439520dexfilingfees.htm | EX-FILING FEES | 30207
6 | GRAPHIC | g439520g0208014757712.jpg | GRAPHIC | 2430
7 | GRAPHIC | g439520g03p03.jpg | GRAPHIC | 593350
| Complete submission text file | 0001193125-23-029269.txt |  | 1565880

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

EIN.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-269654 | Film No.: 23601230
SIC: 2834 Pharmaceutical Preparations